Get started

AMGN

Biotech Double Bottom (+ Divergence & Bollinger Reversal)Technical Analysis 1. As you see in the chart, we have tested the 200ema 3 times in the past; and it has not trade below it since April 2020. We have made a spinning-bottom on a downtrend, coincidental with a 4th test of the 200ema. 2. RSI and OBV show a positive divergence as the bottom from 2 weeks ago (Test #3) was at a lower level. 3. Bollinger Bands give us another bullish signal, as the first low (Test #3) was outside the lower BB, and the second low (Test #4) was inside the lower BB. Trade Setup A break below Test #3 which is $142.47 could be a potentially good place to set a stop-loss exit. Short-term target to the upside --> $160.5 Mid-term target to the upside --> $170 Trade with care
NASDAQ:IBBLong
by dorfmanmaster
Buy $AMGN - NRPicks Feb 14Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in supportive care products for kidney disease and cancer. Flagship drugs include the red blood cell stimulators Epogen and Aranesp, the immune system stimulants Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen is one of the best positioned in the pharmaceutical industry. In 2020, the company generated higher earnings than in 2019, due to its strong product pipeline. Financially speaking, the company maintains controlled debt levels that it will be able to meet without any problems. Fundamentals: - Value - 8.8% estimated net earnings growth over the next 3 years. - P/E 19x vs. 29.6x industry P/E Technicals: - Price level cross MA 200 - 50 - Williams R% at -91% levels - RSI (41) Neutral - -2.8% average upside during the month On January 28th there was a market correction, which also affected Amgen. Although the correction lasted a couple of days, the share price continued to fall until $232.10. From this point, the stock recovered 2.5% and remains at these levels; however, the recovery channel should continue as there are no clear retracement fundamentals. In terms of technical factors, we can see that the SMA and Williams R% favor a buy decision.
NASDAQ:AMGNLong
by NewroadTrader
Amgen might move down soon according to the RSI....I have changed up how to best display projected movement. In the case of AMGN triggered a SELL on my RSI algorithm on March 19, 2021. Equities nearly always obey the signal and move down, but sometimes it may continue to move up first. I have placed two red boxes and two green boxes on the chart. The larger red box depicts all of the historical movement, from a percentage standpoint, that this stock has moved on the Daily chart after a SELL signal occurred. Therefore, this box represents 100% of previous movement upward before the stock finally moved downward. The smaller red box represents 50% of all historical movement upward, before the stock moved downward. The smaller box is more of a precise target for the potential top in this instance. The green boxes represent the same thing. In this instance, the smaller green box would be my projected target for the final bottom. The black dotted arrow represents median historical movement. Medians are a good metric, but they are just one of many I use when forecasting future movement. As always, the stock could decline the very next bar after the signal without looking back (therefore the red boxes would not come into play) or the stock may never decline (and the green boxes may never come into play). All statistics and the full analysis are available for free as always at the site below.
NASDAQ:AMGNShort
by StockSignaler
Understanding range highs and lows are all you need. #stocksBack on October 27th I made a post highlighting a potential reversal as we approached the range lows from back in June. Over the future months the stock tested the lows, found support, and is not heading toward highs. Range highs and lows and major support and resistance areas have value because they indicate where there is likely to be heavy order flow. In this case it AMGN reacted well and held the lows creating a great risk/reward opportunity.
NASDAQ:AMGN
by IngenuityTrading
2
$AMGN - NR Picks Nov 22Amgen se dedica a descubrir, desarrollar, fabricar y ofrecer terapias humanas en todo el mundo. Se centra en las áreas de inflamación, oncología / hematología, salud ósea, enfermedades cardiovasculares, nefrología y neurociencia. La compañía tuvo una reacción positiva a inicios de mes cuando presentó una actualización de su farmaco para la psoriasis, durante el mes el precio de la accion fue cayendo hasta estar cerca a los niveles pre-reacción. Este retroceso se ve como una oportunidad para Amgen, recordemos que esta compañía es una de las mas importantes del sector. Creemos que el interes de los inversiores durante el mes ha cambiado a compañías que estan brindando actualizaciones sobre el desarrollo de la vacuna contra el COVID-19.
NASDAQ:AMGNLong
by NewroadTrader
AMGEN Inc AMGN stock looks attractive after a strong rallyAMGEN Inc AMGN american stock looks attractive after a strong rally, waiting for a pullback to weekly demand imbalance around $178 to buy the underlying stock. We don't need any fundamental analysis on a stock to take a trading decision but if you are interested, Amgen AMGN has been a laggard. Amgen's slump had to do with the stocks slowing growth outlook combined with the ever present headwinds that the healthcare sector faces heading into an election year.However, Amgen could address its growth slump. That's exactly what management did in August, causing the stock's price to spike. Yet, in the past five weeks Amgen shares have cooled off, giving investors who were previously experiencing fear of missing out the trade, the chance to get into the stock at a discount to recent highs. Where is the place where those investors can plan to buy AMGEN again? Well, if you look at the attached weekly chart technical analysis, the whole movement started at $178 creating a very strong weekly demand level, that's where we can buy AMGEN inc again.
NASDAQ:AMGNLong
by AlfonsoMoreno
Daily AMGN forecast timing analysis by Supply-Demand strength21-Jun Investing strategies by pretiming Investing position about Supply-Demand(S&D) strength: In Rising section of high profit & low risk Supply-Demand(S&D) strength Trend Analysis: In the midst of an upward trend of strong upward momentum price flow marked by the temporary falls and strong rises. Today's S&D strength Flow: Supply-Demand strength has changed from a weak buying flow to a strengthening buying flow again. View a Forecast Candlestick Shape Analysis of 10 days in the future: www.pretiming.com (You can easily create a trading plan.) D+1 Candlestick Color forecast: GREEN Candlestick %D+1 Range forecast: 0.8% (HIGH) ~ 0.1% (LOW), 0.4% (CLOSE) %AVG in case of rising: 1.2% (HIGH) ~ -0.6% (LOW), 0.8% (CLOSE) %AVG in case of falling: 0.5% (HIGH) ~ -1.4% (LOW), -0.8% (CLOSE) Price Forecast Timing Criteria: Price forecast timing is analyzed based on pretiming algorithm of Supply-Demand(S&D) strength.
NASDAQ:AMGNLong
by pretiming